科研动态PubMed 摘要

成人多导睡眠图确诊阻塞性睡眠呼吸暂停患者的代谢综合征:一项系统综述与荟萃分析。

PubMed 学科轮询 · 2026-10-27

完整摘要 · 中文译文

背景/目的:阻塞性睡眠呼吸暂停(OSA)和代谢综合征(MetS)是常见的并存心血管代谢疾病。越来越多的证据表明OSA与MetS之间存在正相关,但缺乏最新的全球数据,导致该关联的真实强度尚不确定。因此,本系统综述和荟萃分析旨在提供关于经多导睡眠图(PSG)确诊OSA的成人MetS风险的更新、全面的证据综合。 方法:按照系统综述和荟萃分析首选报告项目(PRISMA)2020指南,进行了系统综述和三水平随机效应荟萃分析。检索了Ovid MEDLINE(医学文献分析与检索系统在线)、CINAHL(护理与联合健康文献累积索引)、Cochrane和Embase数据库,共获得8072条记录。报告经PSG确诊OSA的成人相较于无OSA者的MetS比值比(OR),或包含可计算这些数据的研究符合纳入标准。使用RoBANS(非随机研究偏倚风险评估工具)评估偏倚风险。进行亚组分析和荟萃回归以探索异质性来源。 结果:共纳入来自24个国家的68项研究,包含74个相关效应量(24,663名经PSG确诊OSA的成人;11,423名无OSA者)。OSA成人发生MetS的比值比是无OSA者的三倍以上(比值比3.33,95%置信区间2.86-3.87;p < 0. 0001)。观察到显著异质性(I2 = 73.8%)。研究设计、地理区域、MetS定义/标准、呼吸暂停-低通气指数OSA诊断阈值及发表年份显著调节了合并估计值(均p < 0.05)。组间体重指数差异越大,MetS的比值比越高(β = 0.14,t = 4.03,p < 0.001),而男性参与者比例越高,MetS的比值比越低(β = - 0.01,t = - 2.81,p < 0.010)。 结论:经PSG确诊OSA的成人患有MetS的比值比超过三倍,且在不同人群中结果一致。因此,建议对所有OSA成人进行早期和常规代谢筛查。未来研究应纳入纵向和遗传数据,以探索OSA与MetS之间的因果联系。 PROSPERO注册号:CRD420251073055。

完整摘要 · 英文原文

BACKGROUND/OBJECTIVE: Obstructive sleep apnoea (OSA) and metabolic syndrome (MetS) are prevalent cardio-metabolic conditions which frequently coexist. Growing evidence indicates a positive association between OSA and MetS, but up-to-date global data are lacking, leaving the true strength of the association uncertain. Therefore, this systematic review and meta-analysis aimed to provide an updated and comprehensive synthesis of evidence on the risk of MetS in adults with polysomnography (PSG)-confirmed OSA. METHODS: A systematic review and three-level random-effects meta-analysis were conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Searches were performed of the Ovid MEDLINE (Medical Literature Analysis and Retrieval System Online), CINAHL (Cumulative Index to Nursing and Allied Health Literature), Cochrane and Embase databases, yielding 8072 records. Studies reporting either odds ratios (OR) for MetS in adults with PSG-confirmed OSA compared to those without OSA, or with data to calculate these, were eligible for inclusion. Risk of bias was assessed using the RoBANS (Risk of Bias Assessment tool for Non-randomised Studies) tool. Subgroup analyses and meta-regression were performed to explore sources of heterogeneity. RESULTS: A total of 68 studies from 24 countries with 74 relevant effect sizes were included (24,663 adults with PSG-confirmed OSA; 11,423 without OSA). Adults with OSA had over threefold higher odds of MetS compared with those without (odds ratio 3.33, 95% confidence interval 2.86-3.87; p < 0.0001). Substantial heterogeneity was noted (I2 = 73.8%). Study design, geographic region, MetS definition/criteria, Apnoea-Hypopnea Index OSA diagnostic threshold and publication year significantly moderated the pooled estimate (all p < 0.05). A larger body mass index difference between groups was associated with higher odds of MetS (β = 0.14, t = 4.03, p < 0.001), whereas a higher proportion of male participants was associated with lower odds of MetS (β = - 0.01, t = - 2.81, p < 0.010). CONCLUSIONS: Adults with PSG-confirmed OSA have over threefold higher odds of having MetS, consistently across diverse populations. Thus, early and routine metabolic screening is recommended for all adults with OSA. Future research should incorporate longitudinal and genetic data to explore causal links between OSA and MetS. PROSPERO REGISTRATION NUMBER: CRD420251073055.

English
Metabolic Syndrome in Adults with Polysomnography-Confirmed Obstructive Sleep Apnoea: A Systematic Review and Meta-analysis.
内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界